Cardiogenic Shock

Successful transcatheter aortic valve replacement was high in patients presenting with cardiogenic shock, and those who survived 30 days demonstrated significant functional improvement and quality of life at 1 year, researchers reported.

For patients presenting with acute MI with cardiogenic shock, the safety of percutaneous microaxial left ventricular assist device use vs. other treatments could not be well established using observational Medicare data, findings show.

Abiomed is recalling specific left ventricular assist device sets used for people with cardiomyopathy due to customer complaints about purge fluid leaking from the sidearm of the pump, according to an FDA press release.

In patients with cardiogenic shock due to acute heart failure, use of a pulmonary artery catheter was associated with reduced risk for in-hospital mortality, according to a retrospective observational study.

Use of a novel miniaturized, expandable percutaneous ventricular assist device was shown to be feasible and potentially safe in a small study of six high-risk patients undergoing PCI, a speaker reported.

Data suggest transcatheter aortic valve replacement with a balloon-expandable valve is an acceptable and safe treatment for patients with aortic stenosis and cardiogenic shock, researchers reported.

Lower socioeconomic status was associated with increased risk for cardiogenic shock, decreased likelihood of transfer to cardiac catheterization and increased odds of 30-day all-cause death, researchers reported.

CHICAGO — In this Healio exclusive, B. Hadley Wilson, MD, FACC, provides his perspective on several late-breaking clinical trials presented at the American Heart Association Scientific Sessions.

CHICAGO — Early veno-arterial extracorporeal membrane oxygenation for cardiogenic shock did not improve outcomes vs. a conservative strategy allowing for downstream extracorporeal membrane oxygenation in case of further hemodynamic decline, a speaker reported.

In a cohort of patients who underwent high-risk PCI, mechanical circulatory support with a microaxial blood pump was linked to lower odds of death, MI and cardiogenic shock compared with use of an intra-aortic balloon pump.